Abstract

For the rare but aggressive insular thyroid carcinoma (ITC), there's no clear evidence to determine whether prophylactic central compartment neck dissection (CCND) is necessary for cN0 disease. This study provides the first evidence that treating cN0 ITC without prophylactic CCND is associated with decreased survival regardless of T staging and administration of RAI therapy. Background. Regarding the rare but aggressive insular thyroid carcinoma (ITC), the value of prophylactic central compartment neck dissection (CCND) for clinically node-negative (cN0) disease is unclear. We aimed to provide the first evidence. Methods. N0 and pN1a ITC patients were identified from the Surveillance, Epidemiology, and End Results database. These patients were divided into thyroid-surgery + CCND group (pN0/pN1a patients confirmed by CCND) and thyroid-surgery group (cN0 patients without CCND). Differences in overall survival (OS) and disease-specific survival (DSS) between the two groups were evaluated. Subgroup analyses were also conducted. Results. Of the overall 112 patients, 44 (39.3%) received CCND. On multivariate analyses, the lobectomy ± isthmusectomy/total-thyroidectomy (Lob/TT) group demonstrated poorer OS and DSS than the Lob/TT + CCND group (P < 0.05). When we separately analyzed patients treated by TT, multivariate analyses showed the TT group still revealed compromised OS and DSS than the TT + CCND group (P < 0.05). Furthermore, absence of CCND independently predicted decreased OS no matter whether radioactive iodine (RAI) was administered. Similar results were obtained for T3/T4 patients. Moreover, for T1/T2 patients receiving CCND, 0/12 died during the study period, while for T1/T2 patients without CCND, 8/23 (34.8%) died, 5/23 (21.7%) due to ITC. Conclusion. Regardless of T staging and RAI treatment, cN0-ITC patients without CCND had decreased survival compared with pN0/pN1a patients receiving CCND. Therefore, if a cN0 patient is diagnosed with ITC, prophylactic CCND may be considered as a secondary procedure (postoperatively diagnosed) or a primary procedure (preoperatively/intraoperatively diagnosed). Prospective studies are expected to validate the conclusion.

Highlights

  • First described by Carcangiu et al in 1984 [1], insular thyroid carcinoma (ITC) is a rare but aggressive thyroid malignancy categorized as the most common subtype of poorly differentiated thyroid carcinoma (PDTC) [2,3,4]

  • 102 patients were recorded as N0, 34 were pN0 receiving central compartment neck dissection (CCND), and 68 patients were cN0 not receiving CCND. 10 patients were diagnosed with pN1a disease, and none of these patients had level VII metastases. e pN0 and pN1a patients undergoing CCND constituted the lobectomy ± isthmusectomy (Lob)/ TT + CCND group (n 44). e 68 cN0 patients without CCND constituted the lobectomy ± isthmusectomy/total-thyroidectomy (Lob/TT) group

  • A significantly higher proportion of patients with ETE was observed in the Lob/TT + CCND group (P 0.038)

Read more

Summary

Introduction

First described by Carcangiu et al in 1984 [1], insular thyroid carcinoma (ITC) is a rare but aggressive thyroid malignancy categorized as the most common subtype of poorly differentiated thyroid carcinoma (PDTC) [2,3,4]. Data from both small series and population-level databases show that ITC is associated with larger tumor size, higher rate of International Journal of Endocrinology extrathyroidal extension (ETE), nodal involvement, and distant metastasis [2, 5,6,7,8]. Several scholars reported that with the use of radioactive iodine (RAI) ablation, total thyroidectomy without CCND could achieve a low locoregional recurrence rate or low postoperative thyroglobulin levels in cN0 patients [11, 12]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call